Search

Search Constraints

You searched for: Author/Creator Tuchman, Sascha A.

Search Results

1. A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202). Issue 12 (6th October 2021)

2. Cross-Sectional Analysis of Clinical Trial Availability and North Carolina Neighborhood Social Vulnerability. Issue 2 (6th February 2023)

3. Efficacy and safety of high‐dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma. Issue 4 (19th January 2017)

6. Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status. Issue 2 (March 2022)

7. Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone ("VCD-Lite") in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma. Issue 3 (May 2017)

8. Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders. Issue 7 (September 2022)

9. Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment. Issue 4 (30th September 2022)